Abbott India Limited (ABBOTINDIA) - Net Assets

Latest as of September 2025: Rs40.11 Billion INR ≈ $433.76 Million USD

Based on the latest financial reports, Abbott India Limited (ABBOTINDIA) has net assets worth Rs40.11 Billion INR (≈ $433.76 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs56.94 Billion ≈ $615.83 Million USD) and total liabilities (Rs16.84 Billion ≈ $182.07 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ABBOTINDIA cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs40.11 Billion
% of Total Assets	70.44%
Annual Growth Rate	16.84%
5-Year Change	62.68%
10-Year Change	254.06%
Growth Volatility	16.27

Abbott India Limited - Net Assets Trend (2005–2025)

This chart illustrates how Abbott India Limited's net assets have evolved over time, based on quarterly financial data. Also explore how large is Abbott India Limited's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Abbott India Limited (2005–2025)

The table below shows the annual net assets of Abbott India Limited from 2005 to 2025. For live valuation and market cap data, see ABBOTINDIA market cap.

Year	Net Assets	Change
2025-03-31	Rs42.33 Billion ≈ $457.80 Million	+14.44%
2024-03-31	Rs36.99 Billion ≈ $400.02 Million	+16.01%
2023-03-31	Rs31.89 Billion ≈ $344.83 Million	+13.08%
2022-03-31	Rs28.20 Billion ≈ $304.95 Million	+8.36%
2021-03-31	Rs26.02 Billion ≈ $281.41 Million	+7.01%
2020-03-31	Rs24.32 Billion ≈ $262.98 Million	+21.07%
2019-03-31	Rs20.09 Billion ≈ $217.22 Million	+18.66%
2018-03-31	Rs16.93 Billion ≈ $183.07 Million	+22.05%
2017-03-31	Rs13.87 Billion ≈ $149.99 Million	+16.00%
2016-03-31	Rs11.96 Billion ≈ $129.30 Million	+27.53%
2015-03-31	Rs9.38 Billion ≈ $101.39 Million	+12.54%
2014-03-31	Rs8.33 Billion ≈ $90.09 Million	+28.79%
2013-03-31	Rs6.47 Billion ≈ $69.96 Million	+18.88%
2012-03-31	Rs5.44 Billion ≈ $58.85 Million	+78.18%
2011-03-31	Rs3.05 Billion ≈ $33.03 Million	+12.46%
2010-03-31	Rs2.72 Billion ≈ $29.37 Million	+22.74%
2009-03-31	Rs2.21 Billion ≈ $23.93 Million	-4.24%
2008-03-31	Rs2.31 Billion ≈ $24.98 Million	-6.02%
2007-03-31	Rs2.46 Billion ≈ $26.58 Million	+13.57%
2006-03-31	Rs2.16 Billion ≈ $23.41 Million	+14.96%
2005-03-31	Rs1.88 Billion ≈ $20.36 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Abbott India Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 2143.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Retained Earnings	Rs32.21 Billion	76.08%
Common Stock	Rs212.50 Million	0.50%
Other Components	Rs9.91 Billion	23.41%
Total Equity	Rs42.33 Billion	100.00%

Abbott India Limited Competitors by Market Cap

The table below lists competitors of Abbott India Limited ranked by their market capitalization.

Company	Market Cap
Soochow Securities Co Ltd SHG:601555	$5.85 Billion
Guangzhou Haige Communications Group Incorporated Co SHE:002465	$5.85 Billion
Genpact Limited NYSE:G	$5.85 Billion
Jiangsu Financial Leasing Co Ltd Class A SHG:600901	$5.85 Billion
QMMM Holdings Limited Ordinary Shares NASDAQ:QMMM	$5.84 Billion
Yonyou Network Technology Co Ltd SHG:600588	$5.84 Billion
Marfrig Global Foods S.A. SA:MRFG3	$5.84 Billion
Century Aluminum Company NASDAQ:CENX	$5.84 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Abbott India Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 36,988,900,000 to 42,331,500,000, a change of 5,342,600,000 (14.4%).
Net income of 14,144,400,000 contributed positively to equity growth.
Dividend payments of 8,712,200,000 reduced retained earnings.
Other comprehensive income decreased equity by 451,000,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Rs14.14 Billion	+33.41%
Dividends Paid	Rs8.71 Billion	-20.58%
Other Comprehensive Income	Rs-451.00 Million	-1.07%
Other Changes	Rs361.40 Million	+0.85%
Total Change	Rs-	14.44%

Book Value vs Market Value Analysis

This analysis compares Abbott India Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 12.77x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 206.42x to 12.77x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2005-03-31	Rs123.22	Rs25435.00	x
2006-03-31	Rs141.65	Rs25435.00	x
2007-03-31	Rs160.87	Rs25435.00	x
2008-03-31	Rs155.32	Rs25435.00	x
2009-03-31	Rs153.51	Rs25435.00	x
2010-03-31	Rs198.58	Rs25435.00	x
2011-03-31	Rs223.31	Rs25435.00	x
2012-03-31	Rs256.08	Rs25435.00	x
2013-03-31	Rs304.41	Rs25435.00	x
2014-03-31	Rs370.77	Rs25435.00	x
2015-03-31	Rs441.20	Rs25435.00	x
2016-03-31	Rs562.65	Rs25435.00	x
2017-03-31	Rs652.70	Rs25435.00	x
2018-03-31	Rs796.62	Rs25435.00	x
2019-03-31	Rs945.25	Rs25435.00	x
2020-03-31	Rs1144.39	Rs25435.00	x
2021-03-31	Rs1224.59	Rs25435.00	x
2022-03-31	Rs1327.00	Rs25435.00	x
2023-03-31	Rs1500.56	Rs25435.00	x
2024-03-31	Rs1740.74	Rs25435.00	x
2025-03-31	Rs1992.07	Rs25435.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Abbott India Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 33.41%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 22.07%
• Asset Turnover: 1.08x
• Equity Multiplier: 1.40x
Recent ROE (33.41%) is above the historical average (26.90%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2005	54.31%	25.24%	1.30x	1.66x	Rs834.22 Million
2006	27.33%	13.30%	1.43x	1.43x	Rs375.16 Million
2007	24.35%	11.73%	1.50x	1.39x	Rs352.79 Million
2008	29.62%	11.51%	1.80x	1.43x	Rs453.28 Million
2009	28.42%	9.44%	1.90x	1.58x	Rs407.46 Million
2010	28.54%	10.19%	1.96x	1.43x	Rs503.55 Million
2011	19.95%	6.16%	2.16x	1.50x	Rs303.97 Million
2012	22.13%	8.34%	1.80x	1.47x	Rs659.79 Million
2013	22.37%	8.99%	1.77x	1.40x	Rs800.15 Million
2014	21.17%	8.92%	1.64x	1.45x	Rs879.66 Million
2015	24.42%	10.24%	1.63x	1.47x	Rs1.35 Billion
2016	21.35%	9.90%	1.59x	1.35x	Rs1.36 Billion
2017	19.95%	9.56%	1.40x	1.49x	Rs1.38 Billion
2018	23.70%	12.16%	1.37x	1.43x	Rs2.32 Billion
2019	22.42%	12.25%	1.25x	1.46x	Rs2.49 Billion
2020	24.38%	14.49%	1.15x	1.46x	Rs3.50 Billion
2021	26.54%	16.03%	1.12x	1.48x	Rs4.30 Billion
2022	28.32%	16.27%	1.16x	1.50x	Rs5.17 Billion
2023	29.78%	17.76%	1.17x	1.43x	Rs6.31 Billion
2024	32.48%	20.54%	1.13x	1.40x	Rs8.31 Billion
2025	33.41%	22.07%	1.08x	1.40x	Rs9.91 Billion

Industry Comparison

This section compares Abbott India Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $22,238,236,735
Average return on equity (ROE) among peers: 6.18%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Abbott India Limited (ABBOTINDIA)	Rs40.11 Billion	54.31%	0.42x	$5.85 Billion
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$988.60 Million	6.59%	1.36x	$27.93 Million
Aarti Drugs Limited (AARTIDRUGS)	$6.52 Billion	21.67%	1.42x	$371.43 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$19.90 Billion	13.69%	0.46x	$725.68 Million
Ajanta Pharma Limited (AJANTPHARM)	$1.16 Billion	12.69%	1.32x	$3.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$6.25 Billion	-40.39%	3.91x	$906.19 Million
Alkem Laboratories Limited (ALKEM)	$88.47 Billion	18.60%	0.59x	$6.98 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.46 Billion	16.82%	0.29x	$178.52 Million
Alembic Pharmaceuticals Limited (APLLTD)	$51.90 Billion	11.24%	0.50x	$1.60 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$8.73 Billion

About Abbott India Limited

NSE:ABBOTINDIA India Drug Manufacturers - Specialty & Generic

Market Cap

$5.85 Billion

Rs540.48 Billion INR

Market Cap Rank

#3239 Global

#147 in India

Share Price

Rs25435.00

Change (1 day)

-0.16%

52-Week Range

Rs25180.00 - Rs35670.00

All Time High

Rs35670.00